Revive Therapeutics Ltd.
Revive Therapeutics Ltd.
CSE Index:
CSE CompositeCurrency:
CAD Revive Therapeutics is a life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Emergency Use Authorization, Orphan Drug, Fast Track, and Breakthrough Therapy designations. Currently, the Company is exploring the use of Bucillamine for the potential treatment of public health medical emergencies and rare inflammatory disorders. Revive is also advancing the development of Psilocybin-based therapeutics through various programs. For more information visit www.ReviveThera.com.
Revive Therapeutics Ltd. (RVV)
0.02
0.005 (33.33%)
Revive Therapeutics Ltd. (RVV)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Bid Size
290,000
Bid Price
0.015
Ask Price
0.02
Ask Size
801,000
Volume
884,666
Last Price
0.02
Tick
Net Change
0.005
Prev Close
0.015
Open
0.015
Day High
0.025
Day Low
0.015
52 Week High
0.035
52 Week Low
0.005
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
300,000
Bid Price
0.01
Ask Price
0.00
Ask Size
0
Volume
0
Last Price
0.005
Tick
Net Change
Prev Close
0.005
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
290,000
Bid Price
0.015
Ask Price
0.02
Ask Size
801,000
Volume
884,666
Last Price
0.02
Tick
Net Change
0.005
Prev Close
0.015
Open
0.015
Day High
0.025
Day Low
0.015
52 Week High
0.035
52 Week Low
0.005
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
300,000
Bid Price
0.01
Ask Price
0.00
Ask Size
0
Volume
0
Last Price
0.005
Tick
Net Change
Prev Close
0.005
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| Anonymous | 100,000 | 0.015 | 0.02 | 784,000 | TD Securities Inc. |
| TD Securities Inc. | 100,000 | 0.015 | 0.02 | 8,000 | National Bank Financial Inc. |
| Aviso Financial Inc. | 30,000 | 0.015 | 0.02 | 9,000 | National Bank Financial Inc. |
| TD Securities Inc. | 60,000 | 0.015 | 0.025 | 307,000 | TD Securities Inc. |
| National Bank Financial Inc. | 60,000 | 0.01 | 0.025 | 6,000 | TD Securities Inc. |
| TD Securities Inc. | 242,000 | 0.01 | 0.025 | 10,000 | Leede Jones Gable |
| TD Securities Inc. | 300,000 | 0.01 | 0.025 | 30,000 | Desjardins Securities Inc. |
| Desjardins Securities Inc. | 310,000 | 0.01 | 0.025 | 37,000 | TD Securities Inc. |
| TD Securities Inc. | 25,000 | 0.01 | 0.025 | 247,000 | TD Securities Inc. |
| National Bank Financial Inc. | 120,000 | 0.01 | 0.025 | 150,000 | National Bank Financial Inc. |
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| Anonymous | 200,000 | 0.01 | 0.00 | 0 | |
| Anonymous | 100,000 | 0.01 | 0.00 | 0 | |
| Instinet Canada Limited | 100,000 | 0.005 | 0.00 | 0 | |
| Anonymous | 600,000 | 0.005 | 0.00 | 0 | |
| Anonymous | 800,000 | 0.005 | 0.00 | 0 | |
| Virtu Canada Corp. | 1,000 | 0.005 | 0.00 | 0 | |
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 4 | 290,000 | 0.015 | 0.02 | 801,000 | 3 |
| 29 | 3,099,000 | 0.01 | 0.025 | 1,170,000 | 12 |
| 106 | 10,857,000 | 0.005 | 0.03 | 649,000 | 8 |
| 0 | 0 | 0.00 | 0.035 | 10,000 | 1 |
| 0 | 0 | 0.00 | 0.04 | 211,000 | 6 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 2 | 300,000 | 0.01 | 0.00 | 0 | 0 |
| 4 | 1,501,000 | 0.005 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| Date/Time | Price | Change | Volume | Buyer | Seller | Venue |
|---|---|---|---|---|---|---|
| Apr 2, 15:38 | 0.02 | 0.005 | 14,000 | RBC Capital Markets | TD Securities Inc. | CSE |
| Apr 2, 15:32 | 0.02 | 0.005 | 10,000 | RBC Capital Markets | TD Securities Inc. | CSE |
| Apr 2, 15:25 | 0.02 | 0.005 | 100,000 | TD Securities Inc. | TD Securities Inc. | CSE |
| Apr 2, 15:18 | 0.02 | 0.005 | 11,000 | Desjardins Securities Inc. | TD Securities Inc. | CSE |
| Apr 2, 15:04 | 0.02 | 0.005 | 479,000 | National Bank Financial Inc. | TD Securities Inc. | CSE |
Company Info
Address
The Canadian Venture Building
82 Richmond Street East
Toronto, ON M5C 1P1
CanadaPhone
888 901-0036Fax
905-248-3355Email
info@revivethera.comWebsite
http://www.revivethera.comListing date
Tuesday, July 23, 2019Transfer Agent
Marrelli Trust Company LimitedAuditor
DNTW LLPSEDAR Information
Filing Type
Any
News Releases
Management's Discussion & Analysis
Financial Statements
Material Change Report
Timeframe
1 week1 month3 month6 month1 yearAll Time
Revive Therapeutics Ltd.
Date:
Jan 8, 2025
Revive Therapeutics Ltd.
Date:
Oct 28, 2024
Revive Therapeutics Ltd.
Date:
Oct 28, 2024
Revive Therapeutics Ltd.
Date:
Feb 23, 2024
Revive Therapeutics Ltd.
Date:
Dec 19, 2023
Revive Therapeutics Ltd.
Date:
Oct 27, 2023
Revive Therapeutics Ltd.
Date:
Oct 27, 2023
Revive Therapeutics Ltd.
Date:
Jan 23, 2023
Revive Therapeutics Ltd.
Date:
Oct 28, 2022
Revive Therapeutics Ltd.
Date:
Oct 28, 2022
Revive Therapeutics Ltd.
Date:
Jul 29, 2022
Revive Therapeutics Ltd.
Date:
Jun 29, 2022
Revive Therapeutics Ltd.
Date:
Oct 25, 2021
Revive Therapeutics Ltd.
Date:
Oct 25, 2021
Revive Therapeutics Ltd.
Date:
Mar 1, 2021
Revive Therapeutics Ltd.
Date:
Jan 26, 2021
Revive Therapeutics Ltd.
Date:
Jan 26, 2021
Revive Therapeutics Ltd.
Date:
Jan 26, 2021
Revive Therapeutics Ltd.
Date:
Jan 26, 2021
Revive Therapeutics Ltd.
Date:
Jan 26, 2021
Revive Therapeutics Ltd.
Date:
Oct 28, 2020
Revive Therapeutics Ltd.
Date:
Oct 28, 2020
Revive Therapeutics Ltd.
Date:
Apr 17, 2020
Revive Therapeutics Ltd.
Date:
Mar 30, 2020
Revive Therapeutics Ltd.
Date:
Oct 25, 2019
Revive Therapeutics Ltd.
Date:
Oct 25, 2019
Revive Therapeutics Ltd.
Date:
Oct 24, 2019
Revive Therapeutics Ltd.
Date:
Feb 14, 2019
Revive Therapeutics Ltd.
Date:
Oct 26, 2018
Revive Therapeutics Ltd.
Date:
Oct 26, 2018
Revive Therapeutics Ltd.
Date:
Oct 19, 2017
Revive Therapeutics Ltd.
Date:
Oct 19, 2017
Revive Therapeutics Ltd.
Date:
Oct 20, 2016
Revive Therapeutics Ltd.
Date:
Aug 31, 2016
Revive Therapeutics Ltd.
Date:
Aug 25, 2016
Revive Therapeutics Ltd.
Date:
Oct 21, 2015
Revive Therapeutics Ltd.
Date:
Oct 8, 2014
Revive Therapeutics Ltd.
Date:
Oct 8, 2014
Revive Therapeutics Ltd.
Date:
Sep 24, 2014
Revive Therapeutics Ltd.
Date:
Feb 27, 2014
Revive Therapeutics Ltd.
Date:
Feb 27, 2014
Revive Therapeutics Ltd.
Date:
Aug 19, 2013
Revive Therapeutics Ltd.
Date:
Aug 19, 2013
Revive Therapeutics Ltd.
Date:
Apr 29, 2013
Revive Therapeutics Ltd.
Date:
Apr 29, 2013
Company Info
Address
The Canadian Venture Building
82 Richmond Street East
Toronto, ON M5C 1P1
CanadaPhone
888 901-0036Fax
905-248-3355Email
info@revivethera.comWebsite
http://www.revivethera.comListing date
Tuesday, July 23, 2019Transfer Agent
Marrelli Trust Company LimitedAuditor
DNTW LLPCapitalization
Issued & Outstanding:
418564269Reserved for Issuance:
77666709News Releases
Bulletins
19/07/2019
2019-0718 – New Listing - Revive Therapeutics Ltd. (RVV)
le 19 juillet/July 2019
The common shares of Revive Therapeutics Ltd. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
